A bis-spiropyran functionalized peptide 1, which exhibits good cell-permeability, excellent biocompatibility and low cytotoxicity, has been developed for reversible and real-time lysosomal tracking.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: